Utrogestan clinical trials
A product of Progesterone; its studies count on that page too.
How each study uses Utrogestan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Utrogestan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 1 Nov 1974 · PROGESTERONE · NDA 009238 (FDA, Drugs@FDA; as Progesterone)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Utrogestan
- 6
Studies by the year they started
10 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 9
National University of Malaysia (1) · King's College Hospital NHS Trust (1) · Simone Broer (1) · Shaare Zedek Medical Center (1) · Calla Lily Clinical Care Ltd (1) · UMC Utrecht (1) · Emory University (1) · Insel Gruppe AG, University Hospital Bern (1)
Often tested with
Tested in the same studies.
Nafarelin (2) · Estradiol, estriol drug combination (1) · 17 alpha-Hydroxyprogesterone Caproate (1)
Related medicines
As reviewed, each with the page that says it.
- A brand or code of Progesterone
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test Utrogestan.
- Dec 2026First in Human Safety and Ease of Use Assessment of 400mg Progesterone Callavid in Women With Luteal Phase InsufficiencyPhase 1 · Calla Lily Clinical Care Ltd
- Mar 2027Comparison of Pregnancy Rates in Modified Natural Frozen Embryo Transfer (FET) Cycle After Luteal Support with GnRH Agonist Versus ProgesteroneEarly Phase 1 · Shaare Zedek Medical Center
Studies
Open first, then newest update. How each study uses Utrogestan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 10
- First in Human Safety and Ease of Use Assessment of 400mg Progesterone Callavid in Women With Luteal Phase InsufficiencyRecruitingPhase 1Calla Lily Clinical Care LtdNCT07136922Written as Cyclogest 400 mg
- Progesterone Luteal Support in Unexplained Infertility ManagementNot yet recruitingPhase 3Simone BroerNCT07738068Written as Utrogestan® 200 mg Soft Capsule
- Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH TreatmentRecruitingPhase 4UMC UtrechtNCT05080569Written as Progesterone Vaginal Product
- Comparison of Pregnancy Rates in Modified Natural Frozen Embryo Transfer (FET) Cycle After Luteal Support with GnRH Agonist Versus ProgesteroneNot yet recruitingEarly Phase 1Shaare Zedek Medical CenterNCT06870266Written as Utrogestan®
- Natural Progesterone for the Treatment of Recurrent GlioblastomaTerminatedEarly Phase 1Emory UniversityNCT05091866Written as Therapeutic Progesterone
- Comparison Between Vaginal Pessary and Progestogen in Twin Pregnancy With Short Cervical LengthCompletedPhase 3National University of MalaysiaNCT04342585Written as Micronised vaginal progesterone
- Progesterone and Resting Energy ExpenditureTerminatedPhase 4Insel Gruppe AG, University Hospital BernNCT04140968Written as Utrogestan
- Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High RespondersStatus unknownPhase 4Assaf-Harofeh Medical CenterNCT04797338Written as Utrogestan
- Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled TrialStatus unknownPhase 2nor zila hassan malekNCT01985594Written as utrogestan
- Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled TrialCompletedPhase 3King's College Hospital NHS TrustNCT00422526Written as Micronised progesterone (Utrogestan)
As the comparator · 3 — what is tested is compared with Utrogestan
- Fasting Bioequivalence Study of 2 Oral Progesterone Soft Capsules 200 mg in 48 Healthy Female SubjectsCompletedPhase 1Joint Stock Company "Farmak"NCT05125640Written as Utrogestan® 200 mg Soft Capsule (Manufacturer by: Cyndea Pharma, S.L., Spain, MAH: Laboratoires Besins International, France)
- Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vaginal RouteCompletedPhase 1Joint Stock Company "Farmak"NCT05125627Written as Utrogestan® 200 mg Soft Capsule (Manufacturer: Cyndea Pharma, S.L., Spain, MAH: Laboratoires Besins International, France)
- Implantation Enhancement by Elective Cryopreservation of All Viable EmbryosCompletedNot applicableUniversitair Ziekenhuis BrusselNCT02148393Written as Utrogestan®